Aerosol and Lobar Administration of a Recombinant Adenovirus to Individuals with Cystic Fibrosis. I. Methods, Safety, and Clinical Implications
Patricia M. Joseph(University of Cincinnati), David P. Meeker, Michael A. Perricone, Rosemary Balfour(Sequenom (United States)), Judith A. St. George, Henry L. Dorkin(Boston Children's Hospital), Samuel C. Wadsworth(Unknown), Brian O’Sullivan(University of Toronto), Mireille Rosenberg, Joseph Oren(Tufts Medical Center), Alan E. Smith, Allen Lapey(Boston Children's Hospital)
Cited by 100
Related Papers
Critical Impact of Radiotherapy Protocol Compliance and Quality in the Treatment of Advanced Head and Neck Cancer: Results From TROG 02.02
|Journal of Clinical Oncology|2010|806
Prognostic Significance of p16 <sup>INK4A</sup> and Human Papillomavirus in Patients With Oropharyngeal Cancer Treated on TROG 02.02 Phase III Trial
|Journal of Clinical Oncology|2010|741
Deintensification Candidate Subgroups in Human Papillomavirus–Related Oropharyngeal Cancer According to Minimal Risk of Distant Metastasis
|Journal of Clinical Oncology|2013|588